These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

228 related items for PubMed ID: 32225123

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. γ-Glutamyl cyclotransferase contributes to tumor progression in high grade serous ovarian cancer by regulating epithelial-mesenchymal transition via activating PI3K/AKT/mTOR pathway.
    Li Y, Wu T, Wang Y, Yang L, Hu C, Chen L, Wu S.
    Gynecol Oncol; 2018 Apr; 149(1):163-172. PubMed ID: 29429592
    [Abstract] [Full Text] [Related]

  • 25. Inflammatory interferon activates HIF-1α-mediated epithelial-to-mesenchymal transition via PI3K/AKT/mTOR pathway.
    Yeh YH, Hsiao HF, Yeh YC, Chen TW, Li TK.
    J Exp Clin Cancer Res; 2018 Mar 27; 37(1):70. PubMed ID: 29587825
    [Abstract] [Full Text] [Related]

  • 26. FAK activates AKT-mTOR signaling to promote the growth and progression of MMTV-Wnt1-driven basal-like mammary tumors.
    Paul R, Luo M, Mo X, Lu J, Yeo SK, Guan JL.
    Breast Cancer Res; 2020 Jun 03; 22(1):59. PubMed ID: 32493400
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. IMPDH2 promotes colorectal cancer progression through activation of the PI3K/AKT/mTOR and PI3K/AKT/FOXO1 signaling pathways.
    Duan S, Huang W, Liu X, Liu X, Chen N, Xu Q, Hu Y, Song W, Zhou J.
    J Exp Clin Cancer Res; 2018 Dec 05; 37(1):304. PubMed ID: 30518405
    [Abstract] [Full Text] [Related]

  • 29. Galectin-1 induces hepatocellular carcinoma EMT and sorafenib resistance by activating FAK/PI3K/AKT signaling.
    Zhang PF, Li KS, Shen YH, Gao PT, Dong ZR, Cai JB, Zhang C, Huang XY, Tian MX, Hu ZQ, Gao DM, Fan J, Ke AW, Shi GM.
    Cell Death Dis; 2016 Apr 21; 7(4):e2201. PubMed ID: 27100895
    [Abstract] [Full Text] [Related]

  • 30. DKK3 knockdown confers negative effects on the malignant potency of head and neck squamous cell carcinoma cells via the PI3K/Akt and MAPK signaling pathways.
    Katase N, Nishimatsu SI, Yamauchi A, Yamamura M, Fujita S.
    Int J Oncol; 2019 Mar 21; 54(3):1021-1032. PubMed ID: 30569110
    [Abstract] [Full Text] [Related]

  • 31. AIM2 inhibits the proliferation, invasion and migration, and promotes the apoptosis of osteosarcoma cells by inactivating the PI3K/AKT/mTOR signaling pathway.
    Zheng J, Liu C, Shi J, Wen K, Wang X.
    Mol Med Rep; 2022 Feb 21; 25(2):. PubMed ID: 34913077
    [Abstract] [Full Text] [Related]

  • 32. APLNR is involved in ATRA-induced growth inhibition of nasopharyngeal carcinoma and may suppress EMT through PI3K-Akt-mTOR signaling.
    Liu Y, Liu Q, Chen S, Liu Y, Huang Y, Chen P, Li X, Gao G, Xu K, Fan S, Zeng Z, Xiong W, Tan M, Li G, Zhang W.
    FASEB J; 2019 Nov 21; 33(11):11959-11972. PubMed ID: 31408612
    [Abstract] [Full Text] [Related]

  • 33. Ginkgolic Acid Inhibits Invasion and Migration and TGF-β-Induced EMT of Lung Cancer Cells Through PI3K/Akt/mTOR Inactivation.
    Baek SH, Ko JH, Lee JH, Kim C, Lee H, Nam D, Lee J, Lee SG, Yang WM, Um JY, Sethi G, Ahn KS.
    J Cell Physiol; 2017 Feb 21; 232(2):346-354. PubMed ID: 27177359
    [Abstract] [Full Text] [Related]

  • 34. The inhibition of centromere protein K causes anticancer effects in breast carcinoma via effects on the FAK/PI3K/AKT/mTOR pathway.
    Yu J, Wang K, Yang S, Li G.
    Toxicol Appl Pharmacol; 2022 Nov 01; 454():116232. PubMed ID: 36089000
    [Abstract] [Full Text] [Related]

  • 35. Dysregulation of mammalian target of rapamycin pathway in upper tract urothelial carcinoma.
    Munari E, Fujita K, Faraj S, Chaux A, Gonzalez-Roibon N, Hicks J, Meeker A, Nonomura N, Netto GJ.
    Hum Pathol; 2013 Dec 01; 44(12):2668-76. PubMed ID: 24074531
    [Abstract] [Full Text] [Related]

  • 36. DOK7V1 influences the malignant phenotype of lung cancer cells through PI3K/AKT/mTOR and FAK/paxillin signaling pathways.
    Zhao H, Chen G, Ye L, Yu H, Li S, Jiang WG.
    Int J Oncol; 2019 Jan 01; 54(1):381-389. PubMed ID: 30431081
    [Abstract] [Full Text] [Related]

  • 37. Abnormal Protein Glycosylation and Activated PI3K/Akt/mTOR Pathway: Role in Bladder Cancer Prognosis and Targeted Therapeutics.
    Costa C, Pereira S, Lima L, Peixoto A, Fernandes E, Neves D, Neves M, Gaiteiro C, Tavares A, Gil da Costa RM, Cruz R, Amaro T, Oliveira PA, Ferreira JA, Santos LL.
    PLoS One; 2015 Jan 01; 10(11):e0141253. PubMed ID: 26569621
    [Abstract] [Full Text] [Related]

  • 38. Effects of Variant Histology on the Oncologic Outcomes of Patients With Upper Urinary Tract Carcinoma After Radical Nephroureterectomy: A Propensity Score-Matched Analysis.
    Chung HS, Hwang EC, Kim MS, Yu SH, Jung SI, Kang TW, Choi C, Choi SH, Kwon TG, Noh JH, Kim MK, Cho WJ, Kang SG, Kang SH, Cheon J, Seo IY, Chung H, Kim HS, Lee CH, Ku JY, Ha HK, Kim BH, Jeong CW, Ku JH, Kwak C, Kwon D.
    Clin Genitourin Cancer; 2019 Jun 01; 17(3):e394-e407. PubMed ID: 30782419
    [Abstract] [Full Text] [Related]

  • 39. Astaxanthin Inhibits Matrix Metalloproteinase Expression by Suppressing PI3K/AKT/mTOR Activation in Helicobacter pylori-Infected Gastric Epithelial Cells.
    Lee J, Lim JW, Kim H.
    Nutrients; 2022 Aug 20; 14(16):. PubMed ID: 36014933
    [Abstract] [Full Text] [Related]

  • 40. Sinulariolide Inhibits Gastric Cancer Cell Migration and Invasion through Downregulation of the EMT Process and Suppression of FAK/PI3K/AKT/mTOR and MAPKs Signaling Pathways.
    Wu YJ, Lin SH, Din ZH, Su JH, Liu CI.
    Mar Drugs; 2019 Nov 27; 17(12):. PubMed ID: 31783709
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.